Literature DB >> 12686767

Life expectancy of ventriculosubgaleal shunt revisions.

R Shane Tubbs1, Matthew D Smyth, John C Wellons, Jeffrey P Blount, Paul A Grabb, W Jerry Oakes.   

Abstract

The subgaleal shunt has been and is currently used for the temporary bypass of the normal cerebrospinal fluid (CSF) pathways. We retrospectively reviewed all subgaleal shunts placed at the Children's Hospital, Birmingham, Ala., USA, from 1993 to the present and examined the life expectancy of revisions of this temporary method of CSF diversion. The average length of survival of primary, secondary and tertiary subgaleal shunts in this population was 37.4, 32.4 and 19.6 days, respectively. This current review demonstrates that the majority of patients in whom a subgaleal shunt is utilized may continue to obtain therapeutic diversion of their CSF for greater than 2.5 months with intermittent subgaleal shunt revisions. In the majority of cases, this length of time is sufficient to manage and resolve issues that would make ventriculoperitoneal shunting undesirable. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12686767     DOI: 10.1159/000069827

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  11 in total

1.  A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus.

Authors:  John C Wellons; Chevis N Shannon; Abhaya V Kulkarni; Tamara D Simon; Jay Riva-Cambrin; William E Whitehead; W Jerry Oakes; James M Drake; Thomas G Luerssen; Marion L Walker; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-07       Impact factor: 2.375

Review 2.  Ventriculosubgaleal shunting-a comprehensive review and over two-decade surgical experience.

Authors:  Seif Eid; Joe Iwanaga; Rod J Oskouian; Marios Loukas; W Jerry Oakes; R Shane Tubbs
Journal:  Childs Nerv Syst       Date:  2018-07-12       Impact factor: 1.475

3.  Ventriculoperitoneal shunt failure: an institutional review of 2-year survival rates.

Authors:  Chevis N Shannon; Leslie Acakpo-Satchivi; Russell S Kirby; Frank A Franklin; John C Wellons
Journal:  Childs Nerv Syst       Date:  2012-06-17       Impact factor: 1.475

Review 4.  Ventriculoperitoneal shunt as a primary neurosurgical procedure in newborn posthemorrhagic hydrocephalus: report of a series of 47 shunted patients.

Authors:  L Romero; B Ros; F Ríus; L González; J M Medina; A Martín; A Carrasco; M A Arráez
Journal:  Childs Nerv Syst       Date:  2013-07-24       Impact factor: 1.475

Review 5.  Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends.

Authors:  Nigel Peter Symss; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2014-12-30       Impact factor: 1.475

6.  Ventriculosubgaleal shunts in the management of infective hydrocephalus.

Authors:  Rajeev Kariyattil; Kiran Mariswamappa; Dilip Panikar
Journal:  Childs Nerv Syst       Date:  2008-03-19       Impact factor: 1.475

7.  Complications of ventriculosubgaleal shunts in infants and children.

Authors:  R Shane Tubbs; Jason T Banks; Scott Soleau; Matthew D Smyth; John C Wellons; Jeffrey P Blount; Paul A Grabb; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2004-05-07       Impact factor: 1.475

8.  Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus.

Authors:  Vaner Köksal; Suat Öktem
Journal:  Childs Nerv Syst       Date:  2010-03-19       Impact factor: 1.475

9.  Comparison between Ventriculosubgaleal Shunt and Extraventricular Drainage to Treat Acute Hydrocephalus in Adults.

Authors:  Low Siaw Nee; Rahmat Harun; Pulivendhan Sellamuthu; Zamzuri Idris
Journal:  Asian J Neurosurg       Date:  2017 Oct-Dec

Review 10.  Comparison of the use of ventricular access devices and ventriculosubgaleal shunts in posthaemorrhagic hydrocephalus: systematic review and meta-analysis.

Authors:  Daniel M Fountain; Aswin Chari; Dominic Allen; Greg James
Journal:  Childs Nerv Syst       Date:  2015-11-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.